OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
A1LI57

A-1 Ltd

Specialty ChemicalsVerified

A-1 Limited's capital structure is characterized by a debt-to-equity ratio of 0.43, indicating a relatively conservative leverage position compared to the industry median. The company's liquidity position is mixed, with a current ratio of 2.49, suggesting it can cover short-term obligations, but with negative net cash after subtracting total debt. Free cash flow of INR 39.75 million indicates some capacity to fund operations or reduce debt, though operating cash flow is negative at INR -105.26 million. Profitability metrics show a return on equity of 7.35% and a return on assets of 4.96%, which are below the industry median for Specialty Chemicals. The company's operating margin is 2.01% (INR 66.77 million operating income on INR 3.31 billion revenue), and net margin is 1.10% (INR 36.51 million net income), both of which are weak compared to industry peers. Gross margin of 11.83% (INR 392.33 million gross profit) is also below the median for the sector. The company's revenue is concentrated in India, with operations spanning 13 states, but no specific segment breakdown is provided. Transportation services are a key differentiator, but the lack of geographic diversification and segment-specific data limits visibility into risk exposure. The company's revenue concentration in a single country increases vulnerability to domestic economic and regulatory shifts. Growth trajectory is modest, with no specific revenue growth rate provided. The company's capital expenditure of INR -18.33 million suggests minimal investment in expansion or asset renewal. Outlook for the current fiscal year is neutral, with no significant directional change expected in revenue or profitability. The next fiscal year is also projected to show limited growth, with no material changes in operating performance. Risk factors include medium liquidity risk due to negative net cash and a current ratio that, while above 1, does not fully offset the lack of cash reserves. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company's operating cash flow is negative, which could necessitate external financing if free cash flow does not improve. Adjustments in valuation models have not been applied, suggesting no material non-financial adjustments to the company's fundamentals. Recent events include no material filings or transcripts in the provided data. The company's operations remain stable, with no disclosed material changes in business strategy or regulatory environment. The lack of recent events suggests a low-activity period, but also limits visibility into potential catalysts or risks.

30-day price · A1LI-6.98 (-41.6%)
Low$9.78High$17.59Close$9.78As of11 May, 00:00 UTC
Profile
CompanyA-1 Ltd
TickerA1LI.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. A-1 Limited is an India-based company engaged in the wholesale trading of acids and chemicals and provides transportation services through its own fleet of tankers, operating in multiple states across India.

Classification. A-1 Limited is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

A-1 Limited's capital structure is characterized by a debt-to-equity ratio of 0.43, indicating a relatively conservative leverage position compared to the industry median. The company's liquidity position is mixed, with a current ratio of 2.49, suggesting it can cover short-term obligations, but with negative net cash after subtracting total debt. Free cash flow of INR 39.75 million indicates some capacity to fund operations or reduce debt, though operating cash flow is negative at INR -105.26 million. Profitability metrics show a return on equity of 7.35% and a return on assets of 4.96%, which are below the industry median for Specialty Chemicals. The company's operating margin is 2.01% (INR 66.77 million operating income on INR 3.31 billion revenue), and net margin is 1.10% (INR 36.51 million net income), both of which are weak compared to industry peers. Gross margin of 11.83% (INR 392.33 million gross profit) is also below the median for the sector. The company's revenue is concentrated in India, with operations spanning 13 states, but no specific segment breakdown is provided. Transportation services are a key differentiator, but the lack of geographic diversification and segment-specific data limits visibility into risk exposure. The company's revenue concentration in a single country increases vulnerability to domestic economic and regulatory shifts. Growth trajectory is modest, with no specific revenue growth rate provided. The company's capital expenditure of INR -18.33 million suggests minimal investment in expansion or asset renewal. Outlook for the current fiscal year is neutral, with no significant directional change expected in revenue or profitability. The next fiscal year is also projected to show limited growth, with no material changes in operating performance. Risk factors include medium liquidity risk due to negative net cash and a current ratio that, while above 1, does not fully offset the lack of cash reserves. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company's operating cash flow is negative, which could necessitate external financing if free cash flow does not improve. Adjustments in valuation models have not been applied, suggesting no material non-financial adjustments to the company's fundamentals. Recent events include no material filings or transcripts in the provided data. The company's operations remain stable, with no disclosed material changes in business strategy or regulatory environment. The lack of recent events suggests a low-activity period, but also limits visibility into potential catalysts or risks.
Key takeaways
  • A-1 Limited operates with a conservative debt-to-equity ratio of 0.43, but faces liquidity challenges due to negative net cash.
  • Profitability metrics (ROE 7.35%, ROA 4.96%) are below industry medians, with weak operating and net margins.
  • Revenue is concentrated in India, with no segment-specific breakdown, increasing exposure to domestic economic and regulatory risks.
  • Growth is limited, with minimal capital expenditure and no significant directional change expected in the near term.
  • Liquidity risk is medium, and dilution risk is low, but operating cash flow remains negative.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$3.31B
Gross profit$392.3M
Operating income$66.8M
Net income$36.5M
R&D
SG&A
D&A
SBC
Operating cash flow-$105.3M
CapEx-$18.3M
Free cash flow$39.7M
Total assets$736.6M
Total liabilities$239.8M
Total equity$496.8M
Cash & equivalents$20.0M
Long-term debt$215.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$496.8M
Net cash-$195.0M
Current ratio2.5
Debt/Equity0.4
ROA5.0%
ROE7.3%
Cash conversion-2.9%
CapEx/Revenue-0.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricA1LIActivity
Op margin2.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.1%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin11.8%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity43.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:51 UTC#ddd5caee
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:54 UTCJob: 0c858358